Application 214787
- Type
- NDA
- Sponsor
- GILEAD SCIENCES INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | VEKLURY | REMDESIVIR | INJECTABLE;INJECTION | 5MG/ML | Yes | No |
| 002 | VEKLURY | REMDESIVIR | INJECTABLE;INJECTION | 100MG/VIAL | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2901 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2902 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2902 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2902 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2902 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2902 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2902 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |
| 61958-2902 | Veklury | remdesivir | Gilead Sciences, Inc. | NDA | Current |